Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone-sensitive prostate cancer.

Mike WenzelNele WagnerBenedikt HoehCarolin SiechFlorestan KollCristina Cano GarciaMarit AhrensDerya TilkiThomas SteuberMarkus GraefenSéverine BanekFelix K H ChunPhilipp Mandel

Published in: The Prostate (2024)

Significant differences exist between different metastatic patterns of HV and LV and HR and LR criteria. Best prognosis is observed within M1a LV and LR mHSPC patients.

Keyphrases

prostate cancer
lymph node
small cell lung cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
radical prostatectomy
bone mineral density
type diabetes
metabolic syndrome
soft tissue
skeletal muscle
body composition
bone regeneration
bone loss
free survival